-
1
-
-
0027078685
-
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
-
Devane, W. A.; Hanus, L.; Breuer, A.; Pertwee, R. G.; Stevenson, L. A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 1992, 258, 1946-1949
-
(1992)
Science
, vol.258
, pp. 1946-1949
-
-
Devane, W.A.1
Hanus, L.2
Breuer, A.3
Pertwee, R.G.4
Stevenson, L.A.5
Griffin, G.6
Gibson, D.7
Mandelbaum, A.8
Etinger, A.9
Mechoulam, R.10
-
2
-
-
0029904838
-
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
-
Cravatt, B. F.; Giang, D. K.; Mayfield, S. P.; Boger, D. L.; Lerner, R. A.; Gilula, N. B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 1996, 384, 83-87
-
(1996)
Nature
, vol.384
, pp. 83-87
-
-
Cravatt, B.F.1
Giang, D.K.2
Mayfield, S.P.3
Boger, D.L.4
Lerner, R.A.5
Gilula, N.B.6
-
3
-
-
21344432777
-
The endocannabinoid system: A drug discovery perspective
-
Piomelli, D. The endocannabinoid system: a drug discovery perspective Curr. Opin. Invest. Drugs (Thomson Sci.) 2005, 6, 672-679
-
(2005)
Curr. Opin. Invest. Drugs (Thomson Sci.)
, vol.6
, pp. 672-679
-
-
Piomelli, D.1
-
4
-
-
67650088165
-
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs
-
Gaetani, S.; Dipasquale, P.; Romano, A.; Righetti, L.; Cassano, T.; Piomelli, D.; Cuomo, V. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs Int. Rev. Neurobiol. 2009, 85, 57-72
-
(2009)
Int. Rev. Neurobiol.
, vol.85
, pp. 57-72
-
-
Gaetani, S.1
Dipasquale, P.2
Romano, A.3
Righetti, L.4
Cassano, T.5
Piomelli, D.6
Cuomo, V.7
-
5
-
-
29444460231
-
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
-
Gobbi, G.; Bambico, F. R.; Mangieri, R.; Bortolato, M.; Campolongo, P.; Solinas, M.; Cassano, T.; Morgese, M. G.; Debonnel, G.; Duranti, A.; Tontini, A.; Tarzia, G.; Mor, M.; Trezza, V.; Goldberg, S. R.; Cuomo, V.; Piomelli, D. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 18620-18625
-
(2005)
Proc. Natl. Acad. Sci. U.S.A.
, vol.102
, pp. 18620-18625
-
-
Gobbi, G.1
Bambico, F.R.2
Mangieri, R.3
Bortolato, M.4
Campolongo, P.5
Solinas, M.6
Cassano, T.7
Morgese, M.G.8
Debonnel, G.9
Duranti, A.10
Tontini, A.11
Tarzia, G.12
Mor, M.13
Trezza, V.14
Goldberg, S.R.15
Cuomo, V.16
Piomelli, D.17
-
6
-
-
79959506821
-
Mechanistic and pharmacological characterization of PF-04457845: A highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain
-
Ahn, K.; Smith, S. E.; Liimatta, M. B.; Beidler, D.; Sadagopan, N.; Dudley, D. T.; Young, T.; Wren, P.; Zhang, Y.; Swaney, S.; Van Becelaere, K.; Blankman, J. L.; Nomura, D. K.; Bhattachar, S. N.; Stiff, C.; Nomanbhoy, T. K.; Weerapana, E.; Johnson, D. S.; Cravatt, B. F. Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain J. Pharmacol. Exp. Ther. 2011, 338, 114-124
-
(2011)
J. Pharmacol. Exp. Ther.
, vol.338
, pp. 114-124
-
-
Ahn, K.1
Smith, S.E.2
Liimatta, M.B.3
Beidler, D.4
Sadagopan, N.5
Dudley, D.T.6
Young, T.7
Wren, P.8
Zhang, Y.9
Swaney, S.10
Van Becelaere, K.11
Blankman, J.L.12
Nomura, D.K.13
Bhattachar, S.N.14
Stiff, C.15
Nomanbhoy, T.K.16
Weerapana, E.17
Johnson, D.S.18
Cravatt, B.F.19
-
7
-
-
79955383220
-
Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: Orally active, long-acting analgesics
-
Ezzili, C.; Mileni, M.; McGlinchey, N.; Long, J. Z.; Kinsey, S. G.; Hochstatter, D. G.; Stevens, R. C.; Lichtman, A. H.; Cravatt, B. F.; Bilsky, E. J.; Boger, D. L. Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics J. Med. Chem. 2011, 54, 2805-2822
-
(2011)
J. Med. Chem.
, vol.54
, pp. 2805-2822
-
-
Ezzili, C.1
Mileni, M.2
McGlinchey, N.3
Long, J.Z.4
Kinsey, S.G.5
Hochstatter, D.G.6
Stevens, R.C.7
Lichtman, A.H.8
Cravatt, B.F.9
Bilsky, E.J.10
Boger, D.L.11
-
8
-
-
0037234363
-
Modulation of anxiety through blockade of anandamide hydrolysis
-
Kathuria, S.; Gaetani, S.; Fegley, D.; Valiño, F.; Duranti, A.; Tontini, A.; Mor, M.; Tarzia, G.; La Rana, G.; Calignano, A.; Giustino, A.; Tattoli, M.; Palmery, M.; Cuomo, V.; Piomelli, D. Modulation of anxiety through blockade of anandamide hydrolysis Nat. Med. (N. Y.) 2003, 9, 76-81
-
(2003)
Nat. Med. (N. Y.)
, vol.9
, pp. 76-81
-
-
Kathuria, S.1
Gaetani, S.2
Fegley, D.3
Valiño, F.4
Duranti, A.5
Tontini, A.6
Mor, M.7
Tarzia, G.8
La Rana, G.9
Calignano, A.10
Giustino, A.11
Tattoli, M.12
Palmery, M.13
Cuomo, V.14
Piomelli, D.15
-
9
-
-
54349109924
-
Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates
-
Justinova, Z.; Mangieri, R. A.; Bortolato, M.; Chefer, S. I.; Mukhin, A. G.; Clapper, J. R.; King, A. R.; Redhi, G. H.; Yasar, S.; Piomelli, D.; Goldberg, S. R. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates Biol. Psychiatry 2008, 64, 930-937
-
(2008)
Biol. Psychiatry
, vol.64
, pp. 930-937
-
-
Justinova, Z.1
Mangieri, R.A.2
Bortolato, M.3
Chefer, S.I.4
Mukhin, A.G.5
Clapper, J.R.6
King, A.R.7
Redhi, G.H.8
Yasar, S.9
Piomelli, D.10
Goldberg, S.R.11
-
10
-
-
2242490907
-
Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling
-
Bracey, M. H.; Hanson, M. A.; Masuda, K. R.; Stevens, R. C.; Cravatt, B. F. Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling Science (Washington, DC, U. S.) 2002, 298, 1793-1796
-
(2002)
Science (Washington, DC, U. S.)
, vol.298
, pp. 1793-1796
-
-
Bracey, M.H.1
Hanson, M.A.2
Masuda, K.R.3
Stevens, R.C.4
Cravatt, B.F.5
-
11
-
-
22244484464
-
Structure and function of fatty acid amide hydrolase
-
McKinney, M. K.; Cravatt, B. F. Structure and function of fatty acid amide hydrolase Annu. Rev. Biochem. 2005, 74, 411-432
-
(2005)
Annu. Rev. Biochem.
, vol.74
, pp. 411-432
-
-
McKinney, M.K.1
Cravatt, B.F.2
-
12
-
-
84876745053
-
Latest advances in the discovery of fatty acid amide hydrolase inhibitors
-
Bisogno, T.; Maccarrone, M. Latest advances in the discovery of fatty acid amide hydrolase inhibitors Expert Opin. Drug Discovery 2013, 8, 509-522
-
(2013)
Expert Opin. Drug Discovery
, vol.8
, pp. 509-522
-
-
Bisogno, T.1
MacCarrone, M.2
-
13
-
-
84880950751
-
Chemical probes of endocannabinoid metabolism
-
Blankman, J. L.; Cravatt, B. F. Chemical probes of endocannabinoid metabolism Pharmacol. Rev. 2013, 65, 849-871
-
(2013)
Pharmacol. Rev.
, vol.65
, pp. 849-871
-
-
Blankman, J.L.1
Cravatt, B.F.2
-
14
-
-
84857408437
-
Inhibitors of the endocannabinoid-degrading enzymes, or how to increase endocannabinoid's activity by preventing their hydrolysis
-
Feledziak, M.; Lambert, D. M.; Marchand-Brynaert, J.; Muccioli, G. G. Inhibitors of the endocannabinoid-degrading enzymes, or how to increase endocannabinoid's activity by preventing their hydrolysis Recent Pat. CNS Drug Discovery 2012, 7, 49-70
-
(2012)
Recent Pat. CNS Drug Discovery
, vol.7
, pp. 49-70
-
-
Feledziak, M.1
Lambert, D.M.2
Marchand-Brynaert, J.3
Muccioli, G.G.4
-
15
-
-
79960901769
-
The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH)
-
Otrubova, K.; Ezzili, C.; Boger, D. L. The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH) Bioorg. Med. Chem. Lett. 2011, 21, 4674-4685
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 4674-4685
-
-
Otrubova, K.1
Ezzili, C.2
Boger, D.L.3
-
16
-
-
74549185125
-
FAAH and MAGL inhibitors: Therapeutic opportunities from regulating endocannabinoid levels
-
Petrosino, S.; Di Marzo, V. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels Curr. Opin. Invest. Drugs (BioMed Cent.) 2010, 11, 51-62
-
(2010)
Curr. Opin. Invest. Drugs (BioMed Cent.)
, vol.11
, pp. 51-62
-
-
Petrosino, S.1
Di Marzo, V.2
-
17
-
-
40349114245
-
Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors
-
Vandevoorde, S. Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors Curr. Top. Med. Chem. (Sharjah, United Arab Emirates) 2008, 8, 247-267
-
(2008)
Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)
, vol.8
, pp. 247-267
-
-
Vandevoorde, S.1
-
18
-
-
57349170752
-
Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors
-
Seierstad, M.; Breitenbucher, J. G. Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors J. Med. Chem. 2008, 51, 7327-7343
-
(2008)
J. Med. Chem.
, vol.51
, pp. 7327-7343
-
-
Seierstad, M.1
Breitenbucher, J.G.2
-
19
-
-
4744354729
-
Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: Synthesis, quantitative structure-activity relationships, and molecular modeling studies
-
Mor, M.; Rivara, S.; Lodola, A.; Plazzi, P. V.; Tarzia, G.; Duranti, A.; Tontini, A.; Piersanti, G.; Kathuria, S.; Piomelli, D. Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies J. Med. Chem. 2004, 47, 4998-5008
-
(2004)
J. Med. Chem.
, vol.47
, pp. 4998-5008
-
-
Mor, M.1
Rivara, S.2
Lodola, A.3
Plazzi, P.V.4
Tarzia, G.5
Duranti, A.6
Tontini, A.7
Piersanti, G.8
Kathuria, S.9
Piomelli, D.10
-
20
-
-
79951518976
-
Discovery of PF-04457845: A highly potent, orally bioavailable, and selective urea FAAH inhibitor
-
Johnson, D. S.; Stiff, C.; Lazerwith, S. E.; Kesten, S. R.; Fay, L. K.; Morris, M.; Beidler, D.; Liimatta, M. B.; Smith, S. E.; Dudley, D. T.; Sadagopan, N.; Bhattachar, S. N.; Kesten, S. J.; Nomanbhoy, T. K.; Cravatt, B. F.; Ahn, K. Discovery of PF-04457845: a highly potent, orally bioavailable, and selective urea FAAH inhibitor ACS Med. Chem. Lett. 2011, 2, 91-96
-
(2011)
ACS Med. Chem. Lett.
, vol.2
, pp. 91-96
-
-
Johnson, D.S.1
Stiff, C.2
Lazerwith, S.E.3
Kesten, S.R.4
Fay, L.K.5
Morris, M.6
Beidler, D.7
Liimatta, M.B.8
Smith, S.E.9
Dudley, D.T.10
Sadagopan, N.11
Bhattachar, S.N.12
Kesten, S.J.13
Nomanbhoy, T.K.14
Cravatt, B.F.15
Ahn, K.16
-
21
-
-
84867369139
-
Aryl piperazinyl ureas as inhibitors of fatty acid amide hydrolase (FAAH) in rat, dog, and primate
-
Keith, J. M.; Apodaca, R.; Tichenor, M.; Xiao, W.; Jones, W.; Pierce, J.; Seierstad, M.; Palmer, J.; Webb, M.; Karbarz, M.; Scott, B.; Wilson, S.; Luo, L.; Wennerholm, M.; Chang, L.; Brown, S.; Rizzolio, M.; Rynberg, R.; Chaplan, S.; Breitenbucher, J. G. Aryl piperazinyl ureas as inhibitors of fatty acid amide hydrolase (FAAH) in rat, dog, and primate ACS Med. Chem. Lett. 2012, 3, 823-827
-
(2012)
ACS Med. Chem. Lett.
, vol.3
, pp. 823-827
-
-
Keith, J.M.1
Apodaca, R.2
Tichenor, M.3
Xiao, W.4
Jones, W.5
Pierce, J.6
Seierstad, M.7
Palmer, J.8
Webb, M.9
Karbarz, M.10
Scott, B.11
Wilson, S.12
Luo, L.13
Wennerholm, M.14
Chang, L.15
Brown, S.16
Rizzolio, M.17
Rynberg, R.18
Chaplan, S.19
Breitenbucher, J.G.20
more..
-
22
-
-
20144377098
-
Discovery of a potent, selective, and efficacious class of reversible α -ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics
-
Boger, D. L.; Miyauchi, H.; Du, W.; Hardouin, C.; Fecik, R. A.; Cheng, H.; Hwang, I.; Hedrick, M. P.; Leung, D.; Acevedo, O.; GuimaraÌes, C. R. W.; Jorgensen, W. L.; Cravatt, B. F. Discovery of a potent, selective, and efficacious class of reversible α -ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics J. Med. Chem. 2005, 48, 1849-1856
-
(2005)
J. Med. Chem.
, vol.48
, pp. 1849-1856
-
-
Boger, D.L.1
Miyauchi, H.2
Du, W.3
Hardouin, C.4
Fecik, R.A.5
Cheng, H.6
Hwang, I.7
Hedrick, M.P.8
Leung, D.9
Acevedo, O.10
Guimaraìes, C.R.W.11
Jorgensen, W.L.12
Cravatt, B.F.13
-
23
-
-
0036678094
-
Brain monoglyceride lipase participating in endocannabinoid inactivation
-
Dinh, T. P.; Carpenter, D.; Leslie, F. M.; Freund, T. F.; Katona, I.; Sensi, S. L.; Kathuria, S.; Piomelli, D. Brain monoglyceride lipase participating in endocannabinoid inactivation Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 10819-10824
-
(2002)
Proc. Natl. Acad. Sci. U.S.A.
, vol.99
, pp. 10819-10824
-
-
Dinh, T.P.1
Carpenter, D.2
Leslie, F.M.3
Freund, T.F.4
Katona, I.5
Sensi, S.L.6
Kathuria, S.7
Piomelli, D.8
-
24
-
-
84875424144
-
Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase
-
Aaltonen, N.; Savinainen, J. R.; Ribas, C. R.; Rönkkö, J.; Kuusisto, A.; Korhonen, J.; Navia-Paldanius, D.; Häyrinen, J.; Takabe, P.; Käsnänen, H.; Pantsar, T.; Laitinen, T.; Lehtonen, M.; Pasonen-Seppänen, S.; Poso, A.; Nevalainen, T.; Laitinen, J. T. Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase Chem. Biol. 2013, 20, 379-390
-
(2013)
Chem. Biol.
, vol.20
, pp. 379-390
-
-
Aaltonen, N.1
Savinainen, J.R.2
Ribas, C.R.3
Rönkkö, J.4
Kuusisto, A.5
Korhonen, J.6
Navia-Paldanius, D.7
Häyrinen, J.8
Takabe, P.9
Käsnänen, H.10
Pantsar, T.11
Laitinen, T.12
Lehtonen, M.13
Pasonen-Seppänen, S.14
Poso, A.15
Nevalainen, T.16
Laitinen, J.T.17
-
25
-
-
68149170903
-
Screening of various hormone-sensitive lipase inhibitors as endocannabinoid-hydrolyzing enzyme inhibitors
-
Minkkilä, A.; Savinainen, J. R.; Käsnänen, H.; Xhaard, H.; Nevalainen, T.; Laitinen, J. T.; Poso, A.; Leppänen, J.; Saario, S. M. Screening of various hormone-sensitive lipase inhibitors as endocannabinoid- hydrolyzing enzyme inhibitors ChemMedChem 2009, 4, 1253-1259
-
(2009)
ChemMedChem
, vol.4
, pp. 1253-1259
-
-
Minkkilä, A.1
Savinainen, J.R.2
Käsnänen, H.3
Xhaard, H.4
Nevalainen, T.5
Laitinen, J.T.6
Poso, A.7
Leppänen, J.8
Saario, S.M.9
-
26
-
-
84878526504
-
1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling
-
Käsnänen, H.; Minkkilä, A.; Taupila, S.; Patel, J. Z.; Parkkari, T.; Lahtela-Kakkonen, M.; Saario, S. M.; Nevalainen, T.; Poso, A. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling Eur. J. Pharm. Sci. 2013, 49, 423-433
-
(2013)
Eur. J. Pharm. Sci.
, vol.49
, pp. 423-433
-
-
Käsnänen, H.1
Minkkilä, A.2
Taupila, S.3
Patel, J.Z.4
Parkkari, T.5
Lahtela-Kakkonen, M.6
Saario, S.M.7
Nevalainen, T.8
Poso, A.9
-
27
-
-
80052352965
-
Design, synthesis, and structure-activity relationships of 1,3,4-oxadiazol-2(3 H)-ones as novel FAAH inhibitors
-
Kiss, L. E.; Ferreira, H. S.; Beliaev, A.; Torrão, L.; Bonifáciob, M. J.; Learmonth, D. A. Design, synthesis, and structure-activity relationships of 1,3,4-oxadiazol-2(3 H)-ones as novel FAAH inhibitors Med. Chem. Commun. 2011, 2, 889-894
-
(2011)
Med. Chem. Commun.
, vol.2
, pp. 889-894
-
-
Kiss, L.E.1
Ferreira, H.S.2
Beliaev, A.3
Torrão, L.4
Bonifáciob, M.J.5
Learmonth, D.A.6
-
28
-
-
68249100483
-
Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid
-
Prusakiewicz, J. J.; Duggan, K. C.; Rouzer, C. A.; Marnett, L. J. Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid Biochemistry 2009, 48, 7353-7355
-
(2009)
Biochemistry
, vol.48
, pp. 7353-7355
-
-
Prusakiewicz, J.J.1
Duggan, K.C.2
Rouzer, C.A.3
Marnett, L.J.4
-
29
-
-
80054953106
-
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2
-
Duggan, K. C.; Hermanson, D. J.; Musee, J.; Prusakiewicz, J. J.; Scheib, J. L.; Carter, B. D.; Banerjee, S.; Oates, J. A.; Marnett, L. J. (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2 Nat. Chem. Biol. 2011, 7, 803-809
-
(2011)
Nat. Chem. Biol.
, vol.7
, pp. 803-809
-
-
Duggan, K.C.1
Hermanson, D.J.2
Musee, J.3
Prusakiewicz, J.J.4
Scheib, J.L.5
Carter, B.D.6
Banerjee, S.7
Oates, J.A.8
Marnett, L.J.9
-
30
-
-
84874184618
-
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide
-
Fowler, C. J.; Björklund, E.; Lichtman, A. H.; Naidu, P. S.; Congiu, C.; Onnis, V. Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide J. Enzyme Inhib. Med. Chem. 2013, 28, 172-182
-
(2013)
J. Enzyme Inhib. Med. Chem.
, vol.28
, pp. 172-182
-
-
Fowler, C.J.1
Björklund, E.2
Lichtman, A.H.3
Naidu, P.S.4
Congiu, C.5
Onnis, V.6
-
31
-
-
0030730417
-
Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship
-
Fowler, C. J.; Tiger, G.; Stenström, A. Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship J. Pharmacol. Exp. Ther. 1997, 283, 729-734
-
(1997)
J. Pharmacol. Exp. Ther.
, vol.283
, pp. 729-734
-
-
Fowler, C.J.1
Tiger, G.2
Stenström, A.3
-
32
-
-
0037320223
-
Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner
-
Fowler, C. J.; Holt, S.; Tiger, G. Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner J. Enzyme Inhib. Med. Chem. 2003, 18, 55-58
-
(2003)
J. Enzyme Inhib. Med. Chem.
, vol.18
, pp. 55-58
-
-
Fowler, C.J.1
Holt, S.2
Tiger, G.3
-
33
-
-
0033557114
-
Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen
-
Fowler, C. J.; Janson, U.; Johnson, R. M.; Wahlström, G.; Stenström, A.; Norstrom, K.; Tiger, G. Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen Arch. Biochem. Biophys. 1999, 362, 191-196
-
(1999)
Arch. Biochem. Biophys.
, vol.362
, pp. 191-196
-
-
Fowler, C.J.1
Janson, U.2
Johnson, R.M.3
Wahlström, G.4
Stenström, A.5
Norstrom, K.6
Tiger, G.7
-
34
-
-
84872104107
-
A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase
-
Bertolacci, L.; Romeo, E.; Veronesi, M.; Magotti, P.; Albani, C.; Dionisi, M.; Lambruschini, C.; Scarpelli, R.; Cavalli, A.; De Vivo, M.; Piomelli, D.; Garau, G. A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase J. Am. Chem. Soc. 2013, 135, 22-25
-
(2013)
J. Am. Chem. Soc.
, vol.135
, pp. 22-25
-
-
Bertolacci, L.1
Romeo, E.2
Veronesi, M.3
Magotti, P.4
Albani, C.5
Dionisi, M.6
Lambruschini, C.7
Scarpelli, R.8
Cavalli, A.9
De Vivo, M.10
Piomelli, D.11
Garau, G.12
-
35
-
-
84865277383
-
NSAIDs: Endocannabinoid stimulating anti-inflammatory drugs?
-
Fowler, C. J. NSAIDs: endocannabinoid stimulating anti-inflammatory drugs? Trends Pharmacol. Sci. 2012, 33, 468-473
-
(2012)
Trends Pharmacol. Sci.
, vol.33
, pp. 468-473
-
-
Fowler, C.J.1
-
36
-
-
34249091033
-
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin
-
Holt, S.; Paylor, B.; Boldrup, L.; Alajakku, K.; Vandevoorde, S.; Sundström, A.; Cocco, M. T.; Onnis, V.; Fowler, C. J. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin Eur. J. Pharmacol. 2007, 565, 26-36
-
(2007)
Eur. J. Pharmacol.
, vol.565
, pp. 26-36
-
-
Holt, S.1
Paylor, B.2
Boldrup, L.3
Alajakku, K.4
Vandevoorde, S.5
Sundström, A.6
Cocco, M.T.7
Onnis, V.8
Fowler, C.J.9
-
37
-
-
77955558082
-
Chemistry around imidazopyrazine and ibuprofen: Discovery of novel fatty acid amide hydrolase (FAAH) inhibitors
-
De Wael, F.; Muccioli, G. G.; Lambert, D. M.; Sergent, T.; Schneider, Y. J.; Rees, J. F.; Marchand-Brynaert, J. Chemistry around imidazopyrazine and ibuprofen: discovery of novel fatty acid amide hydrolase (FAAH) inhibitors Eur. J. Med. Chem. 2010, 45, 3564-3574
-
(2010)
Eur. J. Med. Chem.
, vol.45
, pp. 3564-3574
-
-
De Wael, F.1
Muccioli, G.G.2
Lambert, D.M.3
Sergent, T.4
Schneider, Y.J.5
Rees, J.F.6
Marchand-Brynaert, J.7
-
38
-
-
84867750821
-
Identification and characterization of carprofen as a multitarget fatty acid amide hydrolase/cyclooxygenase inhibitor
-
Favia, A. D.; Habrant, D.; Scarpelli, R.; Migliore, M.; Albani, C.; Bertozzi, S. M.; Dionisi, M.; Tarozzo, G.; Piomelli, D.; Cavalli, A.; De Vivo, M. Identification and characterization of carprofen as a multitarget fatty acid amide hydrolase/cyclooxygenase inhibitor J. Med. Chem. 2012, 55, 8807-8826
-
(2012)
J. Med. Chem.
, vol.55
, pp. 8807-8826
-
-
Favia, A.D.1
Habrant, D.2
Scarpelli, R.3
Migliore, M.4
Albani, C.5
Bertozzi, S.M.6
Dionisi, M.7
Tarozzo, G.8
Piomelli, D.9
Cavalli, A.10
De Vivo, M.11
-
39
-
-
84861635055
-
Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates
-
Chang, J. W.; Niphakis, M. J.; Lum, K. M.; Cognetta, A. B., III; Wang, C.; Matthews, M. L.; Niessen, S.; Buczynski, M. W.; Parsons, L. H.; Cravatt, B. F. Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates Chem. Biol. 2012, 19, 579-588
-
(2012)
Chem. Biol.
, vol.19
, pp. 579-588
-
-
Chang, J.W.1
Niphakis, M.J.2
Lum, K.M.3
Cognetta III, A.B.4
Wang, C.5
Matthews, M.L.6
Niessen, S.7
Buczynski, M.W.8
Parsons, L.H.9
Cravatt, B.F.10
-
40
-
-
84863110189
-
Synthesis and pharmacological evaluation of 2,4- dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors
-
Kapanda, C. N.; Masquelier, J.; Labar, G.; Muccioli, G. G.; Poupaert, J. H.; Lambert, D. M. Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors J. Med. Chem. 2012, 55, 5774-5783
-
(2012)
J. Med. Chem.
, vol.55
, pp. 5774-5783
-
-
Kapanda, C.N.1
Masquelier, J.2
Labar, G.3
Muccioli, G.G.4
Poupaert, J.H.5
Lambert, D.M.6
-
41
-
-
77649198453
-
Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases
-
Long, J. Z.; Jin, X.; Adibekian, A.; Li, W.; Cravatt, B. F. Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases J. Med. Chem. 2010, 53, 1830-1842
-
(2010)
J. Med. Chem.
, vol.53
, pp. 1830-1842
-
-
Long, J.Z.1
Jin, X.2
Adibekian, A.3
Li, W.4
Cravatt, B.F.5
-
42
-
-
36048978697
-
Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity
-
Ahn, K.; Johnson, D. S.; Fitzgerald, L. R.; Liimatta, M.; Arendse, A.; Stevenson, T.; Lund, E. T.; Nugent, R. A.; Nomanbhoy, T. K.; Alexander, J. P.; Cravatt, B. F. Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity Biochemistry 2007, 46, 13019-13030
-
(2007)
Biochemistry
, vol.46
, pp. 13019-13030
-
-
Ahn, K.1
Johnson, D.S.2
Fitzgerald, L.R.3
Liimatta, M.4
Arendse, A.5
Stevenson, T.6
Lund, E.T.7
Nugent, R.A.8
Nomanbhoy, T.K.9
Alexander, J.P.10
Cravatt, B.F.11
-
43
-
-
12944277105
-
Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide
-
Boger, D. L.; Sato, H.; Lerner, A. E.; Hedrick, M. P.; Fecik, R. A.; Miyauchi, H.; Wilkie, G. D.; Austin, B. J.; Patricelli, M. P.; Cravatt, B. F. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 5044-5049
-
(2000)
Proc. Natl. Acad. Sci. U.S.A.
, vol.97
, pp. 5044-5049
-
-
Boger, D.L.1
Sato, H.2
Lerner, A.E.3
Hedrick, M.P.4
Fecik, R.A.5
Miyauchi, H.6
Wilkie, G.D.7
Austin, B.J.8
Patricelli, M.P.9
Cravatt, B.F.10
-
44
-
-
2142674647
-
-
Tight Binding Inhibitors. 2 nd ed. John Wiley & Sons, Inc. New York, Chapter 9
-
Copeland, R. A. Tight Binding Inhibitors. Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis, 2 nd ed.; John Wiley & Sons, Inc.: New York, 2002; Chapter 9, pp 305-317.
-
(2002)
Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis
, pp. 305-317
-
-
Copeland, R.A.1
-
45
-
-
73949109254
-
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo
-
Long, J. Z.; Nomura, D. K.; Vann, R. E.; Walentiny, D. M.; Booker, L.; Jin, X.; Burston, J. J.; Sim-Selley, L. J.; Lichtman, A. H.; Wiley, J. L.; Cravatt, B. F. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 20270-20275
-
(2009)
Proc. Natl. Acad. Sci. U.S.A.
, vol.106
, pp. 20270-20275
-
-
Long, J.Z.1
Nomura, D.K.2
Vann, R.E.3
Walentiny, D.M.4
Booker, L.5
Jin, X.6
Burston, J.J.7
Sim-Selley, L.J.8
Lichtman, A.H.9
Wiley, J.L.10
Cravatt, B.F.11
-
46
-
-
34547789923
-
A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases
-
Li, W.; Blankman, J. L.; Cravatt, B. F. A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases J. Am. Chem. Soc. 2007, 129, 9594-9595
-
(2007)
J. Am. Chem. Soc.
, vol.129
, pp. 9594-9595
-
-
Li, W.1
Blankman, J.L.2
Cravatt, B.F.3
-
47
-
-
84867339289
-
Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12)
-
Navia-Paldanius, D.; Savinainen, J. R.; Laitinen, J. T. Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12) J. Lipid Res. 2012, 53, 2413-2424
-
(2012)
J. Lipid Res.
, vol.53
, pp. 2413-2424
-
-
Navia-Paldanius, D.1
Savinainen, J.R.2
Laitinen, J.T.3
-
48
-
-
0034986485
-
Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide
-
Day, T. A.; Rakhshan, F.; Deutsch, D. G.; Barker, E. L. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide Mol. Pharmacol. 2001, 59, 1369-1375
-
(2001)
Mol. Pharmacol.
, vol.59
, pp. 1369-1375
-
-
Day, T.A.1
Rakhshan, F.2
Deutsch, D.G.3
Barker, E.L.4
-
49
-
-
33646928180
-
Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase
-
Kaczocha, M.; Hermann, A.; Glaser, S. T.; Bojesen, I. N.; Deutsch, D. G. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase J. Biol. Chem. 2006, 281, 9066-9075
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 9066-9075
-
-
Kaczocha, M.1
Hermann, A.2
Glaser, S.T.3
Bojesen, I.N.4
Deutsch, D.G.5
-
50
-
-
0034720298
-
Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol
-
Beltramo, M.; Piomelli, D. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol NeuroReport 2000, 11, 1231-1235
-
(2000)
NeuroReport
, vol.11
, pp. 1231-1235
-
-
Beltramo, M.1
Piomelli, D.2
-
51
-
-
50649112791
-
Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake?
-
Fowler, C. J.; Ghafouri, N. Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? Pharmacol. Res. 2008, 58, 72-76
-
(2008)
Pharmacol. Res.
, vol.58
, pp. 72-76
-
-
Fowler, C.J.1
Ghafouri, N.2
-
52
-
-
77954385220
-
Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: Discovery of a deacylating water molecule and insight into enzyme inactivation
-
Mileni, M.; Kamtekar, S.; Wood, D. C.; Benson, T. E.; Cravatt, B. F.; Stevens, R. C. Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: discovery of a deacylating water molecule and insight into enzyme inactivation J. Mol. Biol. 2010, 400, 743-754
-
(2010)
J. Mol. Biol.
, vol.400
, pp. 743-754
-
-
Mileni, M.1
Kamtekar, S.2
Wood, D.C.3
Benson, T.E.4
Cravatt, B.F.5
Stevens, R.C.6
-
53
-
-
80052788690
-
Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure
-
Lodola, A.; Rivara, S.; Mor, M. Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure Adv. Protein Chem. Struct. Biol. 2011, 85, 1-26
-
(2011)
Adv. Protein Chem. Struct. Biol.
, vol.85
, pp. 1-26
-
-
Lodola, A.1
Rivara, S.2
Mor, M.3
-
54
-
-
33751560057
-
Use of an inhibitor to identify members of the hormone-sensitive lipase family
-
Ben Ali, Y.; Chahinian, H.; Petry, S.; Muller, G.; Lebrun, R.; Verger, R.; Carrière, F.; Mandrich, L.; Rossi, M.; Manco, G.; Sarda, L.; Abousalham, A. Use of an inhibitor to identify members of the hormone-sensitive lipase family Biochemistry 2006, 45, 14183-14191
-
(2006)
Biochemistry
, vol.45
, pp. 14183-14191
-
-
Ben Ali, Y.1
Chahinian, H.2
Petry, S.3
Muller, G.4
Lebrun, R.5
Verger, R.6
Carrière, F.7
Mandrich, L.8
Rossi, M.9
Manco, G.10
Sarda, L.11
Abousalham, A.12
-
56
-
-
80051509102
-
Mechanism of inhibition of fatty acid amide hydrolase by sulfonamide-containing benzothiazoles: Long residence time derived from increased kinetic barrier and not exclusively from thermodynamic potency
-
Tian, G.; Paschetto, K. A.; Gharahdaghi, F.; Gordon, E.; Wilkins, D. E.; Luo, X.; Scott, C. W. Mechanism of inhibition of fatty acid amide hydrolase by sulfonamide-containing benzothiazoles: long residence time derived from increased kinetic barrier and not exclusively from thermodynamic potency Biochemistry 2011, 50, 6867-6878
-
(2011)
Biochemistry
, vol.50
, pp. 6867-6878
-
-
Tian, G.1
Paschetto, K.A.2
Gharahdaghi, F.3
Gordon, E.4
Wilkins, D.E.5
Luo, X.6
Scott, C.W.7
-
57
-
-
84875754855
-
Quantum mechanics/molecular mechanics modeling of fatty acid amide hydrolase reactivation distinguishes substrate from irreversible covalent inhibitors
-
Lodola, A.; Capoferri, L.; Rivara, S.; Tarzia, G.; Piomelli, D.; Mulholland, A.; Mor, M. Quantum mechanics/molecular mechanics modeling of fatty acid amide hydrolase reactivation distinguishes substrate from irreversible covalent inhibitors J. Med. Chem. 2013, 56, 2500-2512
-
(2013)
J. Med. Chem.
, vol.56
, pp. 2500-2512
-
-
Lodola, A.1
Capoferri, L.2
Rivara, S.3
Tarzia, G.4
Piomelli, D.5
Mulholland, A.6
Mor, M.7
-
60
-
-
0141452964
-
WinGX suite for small-molecule single-crystal crystallography
-
Farrugia, L. J. WinGX suite for small-molecule single-crystal crystallography J. Appl. Crystallogr. 1999, 32, 837-838
-
(1999)
J. Appl. Crystallogr.
, vol.32
, pp. 837-838
-
-
Farrugia, L.J.1
-
62
-
-
38349137146
-
Determination of absolute structure using Bayesian statistics on bijvoet differences
-
Hooft, R. W. W.; Straver, L. H.; Spek, A. L. Determination of absolute structure using Bayesian statistics on bijvoet differences J. Appl. Crystallogr. 2008, 41, 96-103
-
(2008)
J. Appl. Crystallogr.
, vol.41
, pp. 96-103
-
-
Hooft, R.W.W.1
Straver, L.H.2
Spek, A.L.3
-
64
-
-
33746718652
-
Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system
-
Saario, S. M.; Poso, A.; Juvonen, R. O.; Järvinen, T.; Salo-Ahen, O. M. H. Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system J. Med. Chem. 2006, 49, 4650-4656
-
(2006)
J. Med. Chem.
, vol.49
, pp. 4650-4656
-
-
Saario, S.M.1
Poso, A.2
Juvonen, R.O.3
Järvinen, T.4
Salo-Ahen, O.M.H.5
-
65
-
-
56749107455
-
Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase
-
Minkkilä, A.; Saario, S. M.; Käsnänen, H.; Leppänen, J.; Poso, A.; Nevalainen, T. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase J. Med. Chem. 2008, 51, 7057-7060
-
(2008)
J. Med. Chem.
, vol.51
, pp. 7057-7060
-
-
Minkkilä, A.1
Saario, S.M.2
Käsnänen, H.3
Leppänen, J.4
Poso, A.5
Nevalainen, T.6
-
66
-
-
0027480087
-
Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
-
Meade, E. A.; Smith, W. L.; DeWitt, D. L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs J. Biol. Chem. 1993, 268, 6610-6614
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 6610-6614
-
-
Meade, E.A.1
Smith, W.L.2
Dewitt, D.L.3
-
67
-
-
77949420579
-
Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors
-
Onnis, V.; Congiu, C.; Björklund, E.; Hempel, F.; Söderström, E.; Fowler, C. J. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors J. Med. Chem. 2010, 53, 2286-2298
-
(2010)
J. Med. Chem.
, vol.53
, pp. 2286-2298
-
-
Onnis, V.1
Congiu, C.2
Björklund, E.3
Hempel, F.4
Söderström, E.5
Fowler, C.J.6
-
68
-
-
84887974159
-
-
version 2.5; Schrödinger, LLC: New York, NY.
-
LigPrep, version 2.5; Schrödinger, LLC: New York, NY, 2012.
-
(2012)
LigPrep
-
-
-
69
-
-
77956064328
-
-
version 2.3; Schrödinger, LLC: New York, NY.
-
Protein Preparation Wizard, Epik, version 2.3; Schrödinger, LLC: New York, NY, 2012.
-
(2012)
Protein Preparation Wizard, Epik
-
-
-
70
-
-
84887920991
-
-
version 5.8; Schrödinger, LLC: New York, NY.
-
Impact, version 5.8; Schrödinger, LLC: New York, NY, 2012.
-
(2012)
Impact
-
-
-
71
-
-
84887978408
-
-
version 3.1; Schrödinger, LLC: New York, NY.
-
Prime, version 3.1; Schrödinger, LLC: New York, NY, 2012.
-
(2012)
Prime
-
-
-
72
-
-
84873407140
-
-
version 5.8; Schrödinger, LLC: New York, NY.
-
Induced Fit Docking Protocol, Glide, version 5.8; Schrödinger, LLC: New York, NY, 2012.
-
(2012)
Induced Fit Docking Protocol, Glide
-
-
-
73
-
-
84887921834
-
-
version 3.1; Schrödinger, LLC: New York, NY.
-
Prime, version 3.1; Schrödinger, LLC: New York, NY, 2012.
-
(2012)
Prime
-
-
-
74
-
-
84855757480
-
-
version 2012.10; Chemical Computing Group Inc. (1010 Sherbooke St. West, Suite No. 910, Montreal, QC, Canada, H3A 2R7).
-
Molecular Operating Environment (MOE), version 2012.10; Chemical Computing Group Inc. (1010 Sherbooke St. West, Suite No. 910, Montreal, QC, Canada, H3A 2R7), 2012.
-
(2012)
Molecular Operating Environment (MOE)
-
-
-
75
-
-
70450206724
-
-
Gaussian Inc. Wallingford, CT.
-
Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A., Jr.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. Gaussian 09; Gaussian Inc.: Wallingford, CT, 2009.
-
(2009)
Gaussian 09
-
-
Frisch, M.J.1
Trucks, G.W.2
Schlegel, H.B.3
Scuseria, G.E.4
Robb, M.A.5
Cheeseman, J.R.6
Montgomery Jr., J.A.7
Vreven, T.8
Kudin, K.N.9
Burant, J.C.10
Millam, J.M.11
Iyengar, S.S.12
Tomasi, J.13
Barone, V.14
Mennucci, B.15
Cossi, M.16
Scalmani, G.17
Rega, N.18
Petersson, G.A.19
Nakatsuji, H.20
Hada, M.21
Ehara, M.22
Toyota, K.23
Fukuda, R.24
Hasegawa, J.25
Ishida, M.26
Nakajima, T.27
Honda, Y.28
Kitao, O.29
Nakai, H.30
Klene, M.31
Li, X.32
Knox, J.E.33
Hratchian, H.P.34
Cross, J.B.35
Bakken, V.36
Adamo, C.37
Jaramillo, J.38
Gomperts, R.39
Stratmann, R.E.40
Yazyev, O.41
Austin, A.J.42
Cammi, R.43
Pomelli, C.44
Ochterski, J.W.45
Ayala, P.Y.46
Morokuma, K.47
Voth, G.A.48
Salvador, P.49
Dannenberg, J.J.50
Zakrzewski, V.G.51
Dapprich, S.52
Daniels, A.D.53
Strain, M.C.54
Farkas, O.55
Malick, D.K.56
Rabuck, A.D.57
Raghavachari, K.58
Foresman, J.B.59
Ortiz, J.V.60
Cui, Q.61
Baboul, A.G.62
Clifford, S.63
Cioslowski, J.64
Stefanov, B.B.65
Liu, G.66
Liashenko, A.67
Piskorz, P.68
Komaromi, I.69
Martin, R.L.70
Fox, D.J.71
Keith, T.72
Al-Laham, M.A.73
Peng, C.Y.74
Nanayakkara, A.75
Challacombe, M.76
Gill, P.M.W.77
Johnson, B.78
Chen, W.79
Wong, M.W.80
Gonzalez, C.81
Pople, J.A.82
more..
-
77
-
-
84887966470
-
-
ArgusLab.
-
ArgusLab. http://www.arguslab.com/arguslab.com/ArgusLab.html.
-
-
-
-
78
-
-
4043162793
-
VEGA-an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming
-
Pedretti, A.; Villa, L.; Vistoli, G. VEGA-an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming J. Comput.-Aided Mol. Des. 2004, 18, 167-173
-
(2004)
J. Comput.-Aided Mol. Des.
, vol.18
, pp. 167-173
-
-
Pedretti, A.1
Villa, L.2
Vistoli, G.3
|